Catalyst Wire Dossier Catalyst Wire Dossier

CILEST

Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for CILEST, covering 2011-06-08 to 2011-06-08. Get the full timeline:

Most recent: Clinical Trial Update: A Study to Evaluate the Exposure of Norelgestromin and Ethinyl Estradiol From Commercial Lots of EVRA (a Transdermal Contraceptive Patch Manufactured by LOHMANN Therapie-Systeme) and CILEST (an Oral Contraceptive) [Phase 1]

See pricing